Skip to main content
SpringerLink
Log in

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Chapter 3 “Tumours of the hypopharynx, larynx, trachea, and parapharyngeal space” of the World Health Organization (WHO) Blue Book 2017 “Classification of Head and Neck Tumours” shows a shortened list of entities, especially due to reducing the number of benign and malignant soft tissue tumours, malignant melanoma and some others, which are transferred to more frequently affected regions of the head and neck. The basic concept of the new edition is to assimilate all advances concerning the discussed tumours in a shorter framework, appropriate for daily work. The main emphasis is on the most frequent lesions and tumors originating from the covering squamous epithelium. Laryngeal and hypopharyngeal conventional squamous cell carcinoma (CSCC), its variants and precursor lesions, occupy a major part of the chapter. New data on etiopathogenesis, with the focus on human papillomavirus (HPV) infection, are discussed in relation to the entities of the squamous epithelium. Although only a small fraction of these lesions are HPV-related, further studies are required for evaluation of the potential prognostic and therapeutic benefit of mRNA HPV determination. In contrast to earlier data, laryngeal and hypopharyngeal verrucous SCC, spindle cell SCC and basaloid SCC are not anymore considered as HPV-related tumours. New data on the pathogenesis of spindle cell SCC exhibiting divergent differentiation by epithelial—mesenchymal transition, are also briefly discussed. The most important innovation is brought by the section on precursor lesions, in which a unified two-tier classification, consisting of low- and high-grade dysplasia, is introduced. The proposed two-tier system can also be transformed into a three-tier classification for treatment purposes, with a distinction between carcinoma in situ and high-grade dysplasia. The reviewed morphological criteria of the proposed system are based on the amended Ljubljana classification. The section on laryngeal neuroendocrine carcinomas (NEC) represents a considerable improvement in terminology and classification. NEC are divided into well-, moderate- and poorly-differentiated neuroendocrine carcinoma. The latter is additionally divided into small cell NEC and large cell NEC (LCNEC). It is of extreme importance that LCNEC, which was associated in the WHO 2005 edition with atypical carcinoid/moderately differentiated neuroendocrine carcinoma, grade II, has now been transferred into the group of poorly differentiated NEC, grade III, displaying a specific morphology and poorer prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Halec G, Holzinger D, Schmitt M, et al. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer. 2013;109(1):172–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Westra WH. The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist. Semin Diagn Pathol. 2015;32(1):42–53.

    Article  PubMed  Google Scholar 

  3. El-Mofty SK. Human papillomavirus related head and neck squamous cell variants. Semin Diagn Pathol. 2015;32(1):23–31.

    Article  PubMed  Google Scholar 

  4. Fusconi M, Campo F, Gallo A, et al. Laryngeal Cancer, HPV DNA vs E6/E7 mRNA test: a systematic review. J Voice. 2016. doi:10.1016/j.jvoice.2016.08.002.

    PubMed  Google Scholar 

  5. Chernock RD, Nussenbaum B, Thorstad WL, et al. Extensive HPV-related carcinoma in situ of the upper aerodigestive tract with ‘nonkeratinizing’ histologic features. Head Neck Pathol. 2014;8(3):322–8.

    Article  PubMed  Google Scholar 

  6. Gale N, Gnepp DR, Poljak M, et al. Laryngeal squamous intraepithelial lesions: an updated review on etiology, classification, molecular changes, and treatment. Adv Anat Pathol. 2016;23(2):84–91.

    Article  CAS  PubMed  Google Scholar 

  7. Zidar N, Gale N, Kojc N, et al. Cadherin-catenin complex and transcription factor snail-1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2008;453(3):267–74.

    Article  CAS  PubMed  Google Scholar 

  8. Zidar N, Boštjančič E, Gale N, et al. Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck-hallmark of epithelial-mesenchymal transition. Hum Pathol. 2011;42(4):482–8.

    Article  CAS  PubMed  Google Scholar 

  9. Gale N, Blagus R, El-Mofty SK, et al. Evaluation of a new grading system for laryngeal squamous intraepithelial lesions-a proposed unified classification. Histopathology. 2014;65(4):456–64.

    Article  PubMed  Google Scholar 

  10. Gale N, Zidar N, Poljak M, et al. Current views and perspectives on classification of squamous intraepithelial lesions of the head and neck. Head Neck Pathol. 2014;8(1):16–23.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lewis JS Jr, Spence DC, Chiosea S, et al. Large cell neuroendocrine carcinoma of the larynx: definition of an entity. Head Neck Pathol. 2010;4(3):198–207.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lewis JS Jr, Ferlito A, Gnepp DR, et al. Terminology and classification of neuroendocrine neoplasms of the larynx. Laryngoscope. 2011;121(6):1187–93.

    Article  PubMed  Google Scholar 

  13. Kao HL, Chang WC, et al. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis. Am J Surg Pathol. 2012;36(2):185–92.

    Article  PubMed  Google Scholar 

  14. Gooi Z, Chan JY, Fakhry C. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope. 2016;126(4):894–900.

    Article  PubMed  Google Scholar 

  15. Chai RC, Lambie D, Verma M, et al. Current trends in the etiology and diagnosis of HPV-related head and neck cancers. Cancer Med. 2015;4(4):596–607.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012;6(Suppl 1):S104–20.

    Article  PubMed  Google Scholar 

  17. Lingen MW, Xiao W, Schmitt A, et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013;49(1):1–8.

    Article  PubMed  Google Scholar 

  18. Chernock RD, Wang X, Gao G, et al. Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Mod Pathol. 2013;26(2):223–31.

    Article  CAS  PubMed  Google Scholar 

  19. Lewis JS Jr, Ukpo OC, Ma XJ, et al. Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas-a tissue microarray study utilizing E6/E7 mRNA in situ hybridization. Histopathology. 2012;60(6):982–91.

    Article  PubMed  Google Scholar 

  20. Li X, Gao L, Li H, et al. Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis. 2013;207(3):479–88.

    Article  CAS  PubMed  Google Scholar 

  21. Morshed K, Polz-Dacewicz M, Szymański M, et al. Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur Arch Otorhinolaryngol. 2008;265(Suppl 1):S89–96.

    Article  PubMed  Google Scholar 

  22. Duray A, Descamps G, Arafa M, et al. High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol. 2011;39(1):51–9.

    PubMed  Google Scholar 

  23. zur Hausen H. Infections causing human cancer. Weinheim: Wiley; 2011. p.145–243.

    Google Scholar 

  24. Bishop JA, Ma XJ, Wang H, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36(12):1874–82.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Gheit T, Abedi-Ardekani B, Carreira C, et al. Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma. J Med Virol. 2014;86(4):642–6.

    Article  CAS  PubMed  Google Scholar 

  26. Gale N. Head and neck cancer and HPV infection. 27th Eroppean congress of pathology, Belgarde, 2015; Sy-24, Abstract.

  27. Masand RP, El-Mofty SK, Ma XJ, et al. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011;5(2):108–16.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Castellsagué X, Alemany L, Quer M, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016. doi:10.1093/jnci/djv403

    PubMed  Google Scholar 

  29. Ereño C, López JI, Sánchez JM, et al. Papillary squamous cell carcinoma of the larynx. J Laryngol Otol. 2001;115(2):164–6.

    Article  PubMed  Google Scholar 

  30. Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33(11):1720–4.

    Article  PubMed  Google Scholar 

  31. Mehrad M, Carpenter DH, Chernock RD, et al. Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus. Am J Surg Pathol. 2013;37(9):1349–56.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Thompson LD, Wenig BM, Heffner DK, et al. Exophytic and papillary squamous cell carcinomas of the larynx: a clinicopathologic series of 104 cases. Otolaryngol Head Neck Surg. 1999;120(5):718–24.

    Article  CAS  PubMed  Google Scholar 

  33. Schick U, Pusztaszeri M, Betz M, et al. Adenosquamous carcinoma of the head and neck: report of 20 cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(3):313–20.

    Article  PubMed  Google Scholar 

  34. del Pino M, Bleeker MC, Quint WG, et al. Comprehensive analysis of human papillomavirus prevalence and the potential role of low-risk types in verrucous carcinoma. Mod Pathol. 2012;25(10):1354–63.

    Article  PubMed  Google Scholar 

  35. Patel KR, Chernock RD, Zhang TR, et al. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus. Hum Pathol. 2013;44(11):2385–92.

    Article  CAS  PubMed  Google Scholar 

  36. Odar K, Kocjan BJ, Hošnjak L, et al. Verrucous carcinoma of the head and neck—not a human papillomavirus-related tumour? J Cell Mol Med. 2014;18(4):635–45.

    Article  CAS  PubMed  Google Scholar 

  37. Watson RF, Chernock RD, Wang X, et al. Spindle cell carcinomas of the head and neck rarely harbor transcriptionally-active human papillomavirus. Head Neck Pathol. 2013;7(3):250–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol. 1996;20(3):277–85.

    Article  CAS  PubMed  Google Scholar 

  39. Choi HR, Sturgis EM, Rosenthal DI, et al. Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas. Am J Surg Pathol. 2003;27(9):1216–20.

    Article  PubMed  Google Scholar 

  40. Kojc N, Zidar N, Gale N, et al. Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck. Virchows Arch. 2009;454(5):549–55.

    Article  CAS  PubMed  Google Scholar 

  41. Gallo A, Degener AM, Pagliuca G, et al. Detection of human papillomavirus and adenovirus in benign and malignant lesions of the larynx. Otolaryngol Head Neck Surg. 2009;141(2):276–81.

    Article  PubMed  Google Scholar 

  42. Waters HH, Seth R, Hoschar AP, et al. Does HPV have a presence in diffuse high grade pre-malignant lesions of the larynx? Laryngoscope. 2010;120(Suppl 4):S201.

    Article  PubMed  Google Scholar 

  43. Mooren JJ, Gültekin SE, Straetmans JM, et al. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias. Int J Cancer. 2014;134(9):2108–17.

    Article  CAS  PubMed  Google Scholar 

  44. Pagliuca G, Martellucci S, Degener AM, et al. Role of human papillomavirus in the pathogenesis of laryngeal dysplasia. Otolaryngol Head Neck Surg. 2014;150(6):1018–23.

    Article  PubMed  Google Scholar 

  45. Karatayli-Ozgursoy S, Bishop JA, Hillel A, et al. Risk factors for dysplasia in recurrent respiratory papillomatosis in an adult and pediatric population. Ann Otol Rhinol Laryngol. 2016;125(3):235–41.

    Article  PubMed  Google Scholar 

  46. Gale N, Pilch BZ, Sidransky D, et al. Epithelial precursor lesions. In Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World health organization classification of tumours. head and neck tumours. Lyon: IARC Press; 2005. p. 140–3.

    Google Scholar 

  47. McLaren KM, Burnett RA, Goodlad JR, et al. Consistency of histopathological reporting of laryngeal dysplasia. The Scottish pathology consistency group. Histopathology. 2000;37(5):460–3.

    Article  CAS  PubMed  Google Scholar 

  48. Fleskens SA, Bergshoeff VE, Voogd AC, et al. Interobserver variability of laryngeal mucosal premalignant lesions: a histopathological evaluation. Mod Pathol. 2011;24(7):892–98.

    Article  PubMed  Google Scholar 

  49. Sarioglu S, Cakalagaoglu F, Elagoz S, et al. Inter-observer agreement in laryngeal pre-neoplastic lesions. Head Neck Pathol. 2010;4(4):276–80.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Weller MD, Nankivell PC, McConkey C, et al. The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta-analysis. Clin Otolaryngol. 2010;35(5):364–72.

    Article  CAS  PubMed  Google Scholar 

  51. Karatayli-Ozgursoy S, Pacheco-Lopez P, Hillel AT, et al. Laryngeal dysplasia, demographics, and treatment: a single-institution, 20-year review. JAMA Otolaryngol Head Neck Surg. 201;141(4):313–8.

  52. Kusafuka K, Ferlito A, Lewis JS Jr, et al. Large cell neuroendocrine carcinoma of the head and neck. Oral Oncol. 2012;48(3):211–5.

    Article  PubMed  Google Scholar 

  53. van der Laan TP, Plaat BE, van der Laan BF, et al. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases. Head Neck. 2015;37(5):707–15.

    Article  PubMed  Google Scholar 

  54. Alos L, Hakim S, Larque AB, et a. p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomas. Virchows Arch. 2016;469(3):277–84.

    Article  CAS  PubMed  Google Scholar 

  55. Thompson ED, Stelow EB, Mills SE, et al. Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 cases with an emphasis on HPV status. Am J Surg Pathol. 2016;40(4):471–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia

    Nina Gale & Nina Zidar

  2. Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

    Mario Poljak

Authors
  1. Nina Gale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Poljak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nina Zidar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nina Gale.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Additional information

Special Issue: World Health Organization Classification Update

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gale, N., Poljak, M. & Zidar, N. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space. Head and Neck Pathol 11, 23–32 (2017). https://doi.org/10.1007/s12105-017-0788-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-017-0788-z

Keywords

Search

Navigation